Ian Read
-
{
- All
- News
- Web Stories
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
UK's Labour Call for Inquiry Into Pfizer's AstraZeneca Bid
Britain's opposition Labour party called on Sunday for an inquiry into a potential takeover of British firm AstraZeneca by US drugmaker Pfizer, accusing the government of "cheerleading" for a deal.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
Pfizer Chief Enters Lion's Den of UK Politics to Sell AstraZeneca Deal
The boss of US drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British jobs in his proposed joint creation with AstraZeneca of a global powerhouse upon which he says the latter's future depends.
-
Pfizer’s Hospital-Drug Problems Won’t Go Away
Investors have mostly been willing to hold their nose over Hospira as Pfizer’s stock surged this year.
-
Trump Says Pfizer Is Rolling Back Drug ‘Price Hikes’
Trump had taken aim at Pfizer over its reported plans for take a series of price increases on Monday.
-
Mnuchin Met With Apple's Cook Before First Tax Plan Release
Mnuchin met with chiefs of Apple, Pfizer and Barclays before Trump released its first outline for the tax overhaul.
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Chief Enters Lion's Den of UK Politics to Sell AstraZeneca Deal
The boss of US drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British jobs in his proposed joint creation with AstraZeneca of a global powerhouse upon which he says the latter's future depends.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
UK's Labour Call for Inquiry Into Pfizer's AstraZeneca Bid
Britain's opposition Labour party called on Sunday for an inquiry into a potential takeover of British firm AstraZeneca by US drugmaker Pfizer, accusing the government of "cheerleading" for a deal.
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
UK's Labour Call for Inquiry Into Pfizer's AstraZeneca Bid
Britain's opposition Labour party called on Sunday for an inquiry into a potential takeover of British firm AstraZeneca by US drugmaker Pfizer, accusing the government of "cheerleading" for a deal.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
Pfizer Chief Enters Lion's Den of UK Politics to Sell AstraZeneca Deal
The boss of US drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British jobs in his proposed joint creation with AstraZeneca of a global powerhouse upon which he says the latter's future depends.
-
Pfizer’s Hospital-Drug Problems Won’t Go Away
Investors have mostly been willing to hold their nose over Hospira as Pfizer’s stock surged this year.
-
Trump Says Pfizer Is Rolling Back Drug ‘Price Hikes’
Trump had taken aim at Pfizer over its reported plans for take a series of price increases on Monday.
-
Mnuchin Met With Apple's Cook Before First Tax Plan Release
Mnuchin met with chiefs of Apple, Pfizer and Barclays before Trump released its first outline for the tax overhaul.
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Chief Enters Lion's Den of UK Politics to Sell AstraZeneca Deal
The boss of US drugmaker Pfizer faces UK lawmakers on Tuesday with a promise and a threat - to protect British jobs in his proposed joint creation with AstraZeneca of a global powerhouse upon which he says the latter's future depends.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
UK's Labour Call for Inquiry Into Pfizer's AstraZeneca Bid
Britain's opposition Labour party called on Sunday for an inquiry into a potential takeover of British firm AstraZeneca by US drugmaker Pfizer, accusing the government of "cheerleading" for a deal.
